Find Research Projects

Search results

• Strategic Investments

  Callender, D.

  9/1/13 → 8/31/25

  Project: Other project

• Strategic Investments

  Callender, D.

  9/1/13 → 8/31/25

  Project: Other project

• Strategic Investments

  Vo, A.

  9/1/13 → 8/31/25

  Project: Other project

• Strategic Investments

  Callender, D.

  9/1/13 → 8/31/25

  Project: Other project

• Strengthening Families Living with HIV in Kenya

  Goodman, M.

  National Inst of Mental Health

  9/1/20 → 8/31/25

  Project: Other project

• Strengthening Families Living with HIV in Kenya

  Goodman, M.

  National Inst of Mental Health

  9/1/20 → 8/31/25

  Project: Other project

• Strategic Investments

  Vo, A.

  9/1/13 → 8/31/25

  Project: Other project

• Strengthening Families Living with HIV in Kenya

  Goodman, M.

  9/1/20 → 8/31/25

  Project: Other project

• Strategic Investments

  Vo, A.

  9/1/13 → 8/31/25

  Project: Other project

• A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety and Tolerability of MT 7117 in Adults and Adolescents with Erythropoietic Protoporphyria or X Linked Protoporphyria

  Anderson, K.

  9/17/20 → 9/16/25

  Project: Other project

• A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety and Tolerability of MT 7117 in Adults and Adolescents with Erythropoietic Protoporphyria or X Linked Protoporphyria

  Anderson, K.

  9/17/20 → 9/16/25

  Project: Other project

• A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety and Tolerability of MT 7117 in Adults and Adolescents with Erythropoietic Protoporphyria or X Linked Protoporphyria

  Anderson, K.

  Mitsubishi Tanabe Pharma

  9/17/20 → 9/16/25

  Project: Other project

• Safe Transitions: Longitudinal Examination of Domestic Violence Transitional Housing Models on Survivor Outcomes

  Wood, L.

  11/1/20 → 10/31/25

  Project: Other project

• Safe Transitions: Longitudinal Examination of Domestic Violence Transitional Housing Models on Survivor Outcomes

  Wood, L.

  11/1/20 → 10/31/25

  Project: Other project

• MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

  Klimberg, V. S.

  Agendia Inc

  12/9/20 → 12/8/25

  Project: Other project

• A Phase 3 International, Multicenter, Open-label Study to Evaluate the Safety and Immunogenicity of 9vHPV Vaccine Administered as 2-dose Regimen with Extended Dosing Intervals in 9- to 14-Year Old Boys and Girls Compared with a Standard 3-dose Regimen

  Rupp, R.

  Merck Sharp & Dohme Corporation

  12/22/20 → 12/21/25

  Project: Other project

• A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction e 40% (L

  Khalife, W.

  Bayer HealthCare Pharmaceuticals

  1/21/21 → 1/20/26

  Project: Other project

• Starling Registry Study

  Saad, A.

  Baxter Healthcare Corporation-Irvine

  1/29/21 → 1/28/26

  Project: Other project

• A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants

  Rupp, R.

  Merck Sharp & Dohme Corporation

  1/29/21 → 1/28/26

  Project: Other project

• Socioeconomic and Cardiovascular Sources of Cross-National Variation in Cognitive Health Among Older Adults

  Wong, R.

  4/1/21 → 1/31/26

  Project: Other project

• Infectious Diseases and Inflammatory Disorders Training Program

  Wang, T.

  2/1/21 → 1/31/26

  Project: Other project

• Infectious Diseases and Inflammatory Disorders Training Program

  Wang, T.

  National Inst of Allergy & Infectious Di

  2/1/21 → 1/31/26

  Project: Other project

• Socioeconomic and Cardiovascular Sources of Cross-National Variation in Cognitive Health Among Older Adults

  Wong, R.

  4/1/21 → 1/31/26

  Project: Other project

• (Pfizer Pregnant COVID Vaccine C4591015) A PHASE 2/3, PLACEBO CONTROLLED, RANDOMIZED, OBSERVER BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A SARS COV 2 RNA VACCINE CANDIDATE (BNT162b2) AGAINST COVID 19 IN HEALTHY PREGNANT WOME

  Saade, G.

  Pfizer, Inc.

  2/10/21 → 2/9/26

  Project: Other project

• Mechanisms of Synaptic Protection in Cognitive Resilience to Alzheimer's Disease Neuropathology

  Limon-Ruiz, A.

  National Inst on Aging

  3/1/21 → 2/28/26

  Project: Other project

• Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses

  Aguilar, P.

  Fogarty International Center

  3/15/21 → 2/28/26

  Project: Other project

• Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses

  Aguilar, P.

  Fogarty International Center

  3/15/21 → 2/28/26

  Project: Other project

• Identifying structural and transcriptional signatures of abnormal chromosomes in single cells

  Nir, G.

  3/1/21 → 2/28/26

  Project: Other project

• Preclinical development of a vaccine for Nipah virus

  Geisbert, T.

  National Inst of Allergy & Infectious Di

  3/11/21 → 2/28/26

  Project: Other project

• AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation

  Cisneros, I.

  National Inst on Drug Abuse

  3/15/21 → 2/28/26

  Project: Other project

• Preclinical development of a vaccine for Nipah virus

  Geisbert, T.

  National Inst of Allergy & Infectious Di

  3/11/21 → 2/28/26

  Project: Other project

• Identifying structural and transcriptional signatures of abnormal chromosomes in single cells

  Nir, G.

  Cancer Prevention and Research Institute

  3/1/21 → 2/28/26

  Project: Other project

• Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses

  Aguilar, P.

  Fogarty International Center

  3/15/21 → 2/28/26

  Project: Other project

• PHASE 1, OPEN-LABEL DOSE-FINDING STUDY TO EVALUATE SAFETY, TOLERABILITY, AND IMMUNOGENICITY AND PHASE 2/3 PLACEBO-CONTROLLED, OBSERVER-BLINDED SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF A SARS-COV-2 RNA VACCINE CANDIDATE AGAINST COVID-19 IN HEALTH

  Rupp, R.

  Pfizer, Inc.

  3/29/21 → 3/28/26

  Project: Other project

• Analysis of intrahepatic macrophage profiles for predicting risk of fibrosis development in patients with different types of chronic liver disease

  Stevenson-Lerner, H.

  National Inst of Diabetes & Digestive &

  4/1/21 → 3/31/26

  Project: Other project

• Analysis of intrahepatic macrophage profiles for predicting risk of fibrosis development in patients with different types of chronic liver disease

  Stevenson-Lerner, H.

  National Inst of Diabetes & Digestive &

  4/1/21 → 3/31/26

  Project: Other project

• Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus

  Bukreyev, A.

  4/15/21 → 3/31/26

  Project: Other project

• Small molecule modulators of FosB

  Rudenko, G.

  National Inst on Drug Abuse

  7/1/21 → 3/31/26

  Project: Other project

• Small molecule modulators of FosB

  Rudenko, G.

  National Inst on Drug Abuse

  7/1/21 → 3/31/26

  Project: Other project

• Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus

  Bukreyev, A.

  4/15/21 → 3/31/26

  Project: Other project

• Small molecule modulators of FosB

  Rudenko, G.

  National Inst on Drug Abuse

  7/1/21 → 3/31/26

  Project: Other project

• Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus

  Bukreyev, A.

  4/15/21 → 3/31/26

  Project: Other project

• Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus

  Bukreyev, A.

  4/15/21 → 3/31/26

  Project: Other project

• Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus

  Bukreyev, A.

  4/15/21 → 3/31/26

  Project: Other project

• High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis

  Zhou, J.

  4/15/21 → 3/31/26

  Project: Other project

• Analysis of intrahepatic macrophage profiles for predicting risk of fibrosis development in patients with different types of chronic liver disease

  Stevenson-Lerner, H.

  National Inst of Diabetes & Digestive &

  4/1/21 → 3/31/26

  Project: Other project

• Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus

  Bukreyev, A.

  4/15/21 → 3/31/26

  Project: Other project

• Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus

  Bukreyev, A.

  4/15/21 → 3/31/26

  Project: Other project

• Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus

  Bukreyev, A.

  4/15/21 → 3/31/26

  Project: Other project

• Small molecule modulators of FosB

  Rudenko, G.

  National Inst on Drug Abuse

  7/1/21 → 3/31/26

  Project: Other project